MDMA-Assisted Psychotherapy Expanded Access program has been accepted by the FDA! The FDA will be allowing only a limited number of patients (less than 50 in the entire country) to enroll outside of the phase III trial. This is an incredible moment in the approval process.

On September 27-29, members of the SoundMind team joined MAPS and the Pittsburgh Psychedelic Society for the Sleeping Octopus Assembly on Psychedelics (SOAP), an annual conference exploring the role of psychedelics in science, medicine, policy, and culture. The event, hosted at a historic mansion in Pittsburgh, PA, featured presentations, panels, and “tentacle” breakout sessions with experts and advocates working to advance psychedelic science, including SoundMind’s own Dr. Hannah McLane, and Dr. Michelle Joy!

We would like to share some of the things we learned at the Psychedelic Medicine and Cultural Trauma workshop in Kentucky, which our entire six-person therapy team attended on August 10–11th. It was an incredible learning and collaborative experience! The workshop was jam-packed with thought-provoking presentations and heartfelt sharing of personal narratives …